z-logo
open-access-imgOpen Access
Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
Author(s) -
Yin Lin,
Li Na,
Jia Weihua,
Wang Nuoqi,
Liang Meidai,
Shang Jiamin,
Qiang Guifen,
Du Guanhua,
Yang Xiuying
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.879
Subject(s) - skeletal muscle , atrophy , muscle atrophy , medicine , endocrinology , inflammation , urotensin ii , glucocorticoid receptor , glucocorticoid , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom